Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.

CONCLUSION: These results suggest ophthalmic 5% PVP-I used as a one-time treatment is safe and well tolerated by patients with Ad-Cs.
PMID: 31401340 [PubMed - as supplied by publisher]

Source: The Ocular Surface - August 7, 2019 Category: Opthalmology Authors: Shorter E, Whiteside M, Harthan J, Margolis M, Hartwick AT, Johnson S, Migneco M, Morettin C, Olson CK, Huecker J, Than T, Gordon MO Tags: Ocul Surf Source Type: research